Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

Code · REGISTER · 2017-05-25 · Food and Drug Administration, HHS · Notices

Notices. Notice

337 words·~2 min read·/register/2017/05/25/2017-10736

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 4120-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket Nos. FDA-2013-N-0879; FDA-2013-N-0579; FDA-2016-N-2474; FDA-2016-D-1853; FDA-2013-N-0764; FDA-2013-N-0825; FDA-2013-N-0797; FDA-2013-N-0578] Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration
(FDA)is publishing a list of information collections that have been approved by the Office of Management and Budget
(OMB)under the Paperwork Reduction Act of 1995. FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 11601 Landsdown Street, North Bethesda, MD 20852, 301-796-7726, *PRAStaff@fda.hhs.gov.* SUPPLEMENTARY INFORMATION: The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the Internet at *https://www.reginfo.gov/public/do/PRAMain.* An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Table 1—List of Information Collections Approved by OMB Title of collection OMB control No. Date approval expires Procedures for the Safe Processing and Importing of Fish and Fishery Products 0910-0354 2/29/2020 Biological Products: Reporting of Biological Product Deviations and Human Cells, Tissues, and Cellular and Tissue-Based Product Deviations; Form FDA 3486 and Addendum, 3486A 0910-0458 2/29/2020 Designation of New Animal Drugs for Minor Use or Minor Species 0910-0605 2/29/2020 Unique Device Identification System 0910-0720 2/29/2020 Animal Feed Regulatory Program Standards 0910-0760 2/29/2020 Premarket Approval of Medical Devices—21 CFR Part 814 0910-0231 3/31/2020 Human Tissue Intended for Transplantation 0910-0302 3/31/2020 General Licensing Provisions: Biological License Application, Changes to an Approved Application, Labeling, Revocation and Suspension, and Form FDA 356h 0910-0338 3/31/2020 Dated: May 18, 2017. Anna K. Abram, Deputy Commissioner for Policy, Planning, Legislative, and Analysis. [FR Doc. 2017-10736 Filed 5-24-17; 8:45 am]
Connectionstraces to 1
1 reference not yet in our index
  • 21 CFR 814
Citation graph
cites case law
Notices
Notice
Cite21 CFR 814
Cites 2Cited by 0 across 0 sources
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.